RYM Ryman Healthcare Limited
Healthcare · Medical Care Facilities
· website
$1.47
52wk 1.47 – 2.64
Overall
29.4
Value
51.7
Growth
41.9
Health
34.3
Quality
5.6
Momentum
0.0
Dividend
—
Price
About Ryman Healthcare Limited
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company's villages provide apartments and townhouses, and assisted-living in serviced apartments, and care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Limited was founded in 1984 and is based in Christchurch, New Zealand.
Price analytics
Returns
| 1 day | -1.7% |
| 1 week | -6.4% |
| 1 month | -12.8% |
| 3 months | -20.1% |
| 6 months | -18.3% |
| 1 year | -39.0% |
| 3 years | — |
Risk
| Volatility (1y ann.) | 41.1% |
| Beta vs ASX 200 | 0.45 |
| Sharpe (1y) | -1.09 |
| VaR 95% (1-day) | -4.7% |
| Max drawdown (1y) | -43.7% |
| Off 1-year high | -43.7% |
Technicals
| RSI(14) | 39 |
| vs 50DMA | -12.9% |
| vs 200DMA | -23.5% |
| Trend | Death cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
51.7
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
0
Price / Book
100
Price / Sales
90
Growth
41.9
Revenue growth (1y)
56
Revenue CAGR (3y)
69
EPS growth (1y)
0
EPS CAGR (3y)
—
Financial Health
34.3
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
0
Debt / Equity
89
Quality (Profitability & Cash Flow)
5.6
Return on equity
0
Return on assets
2
Operating margin
21
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
0.0
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
0
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$1.49B
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.31
Dividend yield
—
Payout ratio
0.0%
Beta
0.34
EV / EBITDA
39.40
Price / Book
0.45
ROE
-4.1%
Operating margin
5.3%
Net margin
-20.1%
Total cash
$20.29M
Total debt
$1.60B
Current ratio
0.04
Debt / Equity
0.39
Free cash flow
$352.43M
Avg volume
4,186
Latest annual results
(FY ending 31 Mar 2025)
- Revenue$713.80M
- Gross profit$713.80M
- Operating income-$118.26M
- Net income-$436.83M
- Diluted EPS—
- Free cash flow$302.89M
- Net debt$1.68B